Topic: flu vaccine

sign on building that says Liverpool

Seqirus adding vax production facility in U.K.

It was just 6 months ago that vaccines specialist CSL closed on its $275 million buyout of Novartis' influenza vaccines operations, getting three additional plants in the process. But the company says more capacity is needed and expansion is already underway in the U.K.
Large office building overlooking water at night

Takeda's Hib vaccine gets Japanese approval

Just days after the U.S. FDA expanded the indication for GlaxoSmithKline's Haemophilus influenzae type B (Hib) vaccine, Takeda picked up a regulatory green light from Japan's Ministry of Health, Labour and Welfare. The vaccine, Vaxem Hib, is approved for use in children aged two months to under 5 years.